Trastuzumab deruxtecan (T-DXd) significantly improves IDFS over trastuzumab emtansine (T-DM1) in high-risk HER2-positive early breast cancer post-neoadjuvant therapy. The DESTINY-Breast05 trial ...
Raludotatug deruxtecan (R-DXd) received FDA breakthrough therapy designation for CDH6-expressing platinum-resistant ovarian, primary peritoneal, or fallopian tube cancers. Phase 1 study demonstrated a ...
AstraZeneca AZN stock has risen 15% so far this year compared with an increase of 0.2% for the industry. The stock has also ...
(Sharecast News) - London stocks nudged lower in early trade on Tuesday as investors considered the implications of a potential US government shutdown and digested the latest UK GDP data. At 0845 BST, ...
When playing through Hades 2, you’re more or less working towards two interconnected final boss fights. The first unfolds through Melinoe’s efforts to defeat Chronos and take back the Underworld. But ...
Post Credits Scene, Season 2 Theories And Review | STAR WARS. We analyze the latest Disney Plus Andor Episode and explain the ending of Episode 12. We also breakdown the post credits scene, what it ...
Hades 2 finally launched out of early access this week, and already, players have reached its 'true ending'. But, ...
Some fans have already managed to unlock the Hades 2 true ending, but a portion of them aren't exactly happy with what they saw.
Deutsche Bank analysts say that one bubble in artificial intelligence may have already deflated — and that is the rush to ...
AstraZeneca and Daiichi Sankyo’s supplemental Biologics License Application for Enhertu plus pertuzumab has been accepted for Priority Review b ...